American Century Companies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
American Century Companies's XBI Position: Q3 2019 in Review
American Century Companies sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 126,403 shares — an estimated $11.1M sold.
American Century Companies first reported a position in XBI in Q4 2018 and held it in 3 quarters. The position peaked at $11.4M in Q1 2019. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.
- American Century Companies reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
- American Century Companies sold 126,403 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $11.1M.
- American Century Companies first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 3 quarters.
- American Century Companies's State Street SPDR S&P Biotech ETF position peaked at $11.4M in Q1 2019.
- 406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.